MMP1 and tuberculosis: Furthermore, the bacteriostatic TB drug para-aminosalicyclic acid exerts its anti-TB activity in part due to inhibition of the prostaglandin pathway, thereby reducing MMP-1 secretion and tissue destruction [14].